Khalid H - Search Results

1

Interferon-Free Regimen for Hepatitis C: Insight and Management.

Masoud MS, Ashfaq UA, Khalid H. Masoud MS, et al. Among authors: khalid h. Crit Rev Eukaryot Gene Expr. 2018;28(4):373-384. doi: 10.1615/CritRevEukaryotGeneExpr.2018025121. Crit Rev Eukaryot Gene Expr. 2018. PMID: 30311586 Review.

2

Mechanism of Hepatitis C Virus-Induced Diabetes Mellitus.

Ashfaq UA, Khalid H. Ashfaq UA, et al. Among authors: khalid h. Crit Rev Eukaryot Gene Expr. 2017;27(4):363-371. doi: 10.1615/CritRevEukaryotGeneExpr.2017020437. Crit Rev Eukaryot Gene Expr. 2017. PMID: 29283331 Review.

3

CRISPR/CAS9-Mediated Antiviral Activity: A Tool to Combat Viral Infection.

Ashfaq UA, Khalid H. Ashfaq UA, et al. Among authors: khalid h. Crit Rev Eukaryot Gene Expr. 2020;30(1):45-56. doi: 10.1615/CritRevEukaryotGeneExpr.2020028207. Crit Rev Eukaryot Gene Expr. 2020. PMID: 32421984 Review.

4

Molecular Docking and Pharmacoinformatics Studies Reveal Potential Phytochemicals Against HCV NS5B Polymerase.

Khalid H, Ashfaq UA. Khalid H, et al. Comb Chem High Throughput Screen. 2022;25(2):335-346. doi: 10.2174/1386207323666201228160224. Comb Chem High Throughput Screen. 2022. PMID: 33371844

5

Discovery of Novel HCV NS5B polymerase inhibitor, 2-(3,4-dimethyl-5,5-dioxidobenzo[e]pyrazolo[4,3-c][1,2]thiazin-2(4H)-yl)-N-(2-fluorobenzyl)acetamide via molecular docking and experimental approach.

Khalid H, Shahid S, Tariq S, Ijaz B, Ashfaq UA, Ahmad M. Khalid H, et al. Clin Exp Pharmacol Physiol. 2021 Dec;48(12):1653-1661. doi: 10.1111/1440-1681.13571. Epub 2021 Sep 6. Clin Exp Pharmacol Physiol. 2021. PMID: 34386985

6

Discovery of novel Hepatitis C virus inhibitor targeting multiple allosteric sites of NS5B polymerase.

Khalid H, Landry KB, Ijaz B, Ashfaq UA, Ahmed M, Kanwal A, Froeyen M, Mirza MU. Khalid H, et al. Infect Genet Evol. 2020 Oct;84:104371. doi: 10.1016/j.meegid.2020.104371. Epub 2020 May 31. Infect Genet Evol. 2020. PMID: 32485331

7

Exploring HCV genome to construct multi-epitope based subunit vaccine to battle HCV infection: Immunoinformatics based approach.

Khalid H, Ashfaq UA. Khalid H, et al. J Biomed Inform. 2020 Aug;108:103498. doi: 10.1016/j.jbi.2020.103498. Epub 2020 Jul 1. J Biomed Inform. 2020. PMID: 32621883 Free article.

8

Immunoinformatics guided rational design of a next generation multi epitope based peptide (MEBP) vaccine by exploring Zika virus proteome.

Shahid F, Ashfaq UA, Javaid A, Khalid H. Shahid F, et al. Among authors: khalid h. Infect Genet Evol. 2020 Jun;80:104199. doi: 10.1016/j.meegid.2020.104199. Epub 2020 Jan 18. Infect Genet Evol. 2020. PMID: 31962160

9

Phytochemical Analysis and Antidiabetic Potential of Armoracia Rusticana: Pharmacological and Computational Approach.

Javaid A, Ashfaq UA, Zafar Z, Akmal A, Taj S, Khalid H. Javaid A, et al. Among authors: khalid h. Comb Chem High Throughput Screen. 2021;24(3):465-471. doi: 10.2174/1386207323666200526134512. Comb Chem High Throughput Screen. 2021. PMID: 32452324

10

In-silico elucidation reveals potential phytochemicals against angiotensin-converting enzyme 2 (ACE-2) receptor to fight coronavirus disease 2019 (COVID-19).

Khalid H, Khalid S, Sufyan M, Ashfaq UA. Khalid H, et al. Among authors: khalid s. Z Naturforsch C J Biosci. 2022 Apr 25;77(11-12):473-482. doi: 10.1515/znc-2021-0325. Print 2022 Nov 25. Z Naturforsch C J Biosci. 2022. PMID: 35470645 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

323 results

Search Page